Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum

Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum

Chemotherapeutic effects of CDDP used as the main drug were studied in 20 patients with progressive prostatic cancer in stage C or D. On the average 208 mg of CDDP was given to the patients receiving chemotherapy without antiandrogen therapy (13 patients who showed resistance to hormone and an untre...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 30(1984), 12 vom: 29. Dez., Seite 1801-7
1. Verfasser: Okumura, S (VerfasserIn)
Weitere Verfasser: Hasegawa, J, Ohhara, M, Kawamura, N, Abe, H, Yui, Y, Kanamori, S, Yoshida, K, Nishimura, T, Tomita, M
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1984
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Androgen Antagonists Acid Phosphatase EC 3.1.3.2 Cisplatin Q20Q21Q62J